Status:
COMPLETED
Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aalborg Psychiatric Hospital
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Brief Summary
Clozapine remain the drug of choice for treatment resistant schizophrenia and up to 60% of patients not responding to other antipsychotics will respond to clozapine. However, the use of clozapine is r...
Eligibility Criteria
Inclusion
- Treated with clozapine
- Compliant with blood monitoring
- Willing to give informed consent
Exclusion
- Prior case of agranulocytosis
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT01138618
Start Date
April 1 2010
End Date
May 1 2011
Last Update
November 7 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Center Roskilde
Greve, Greve, Denmark, 2670
2
Aalborg Psychiatric Hospital
Aalborg, Denmark, 9000
3
Psychiatric Center Aarhus
Aarhus, Denmark, 8240
4
Psychiatric Center Copenhagen
Copenhagen, Denmark